TI
BNTX icon

TT International’s BioNTech BNTX Stock Holding History

TT International’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$1.11M Buy
+16,000
New +$1.15M 0.06% 44

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

TT International's BNTX Position: Q3 2020 in Review

TT International opened a new position in BioNTech (BNTX) in Q3 2020: 16,000 shares worth $1.11M. The stake represents 0.06% of the portfolio and ranks #44 among its holdings.

147 funds tracked by Wall St. Rank hold BNTX as of Q3 2020.

  • TT International held 16,000 shares of BioNTech worth $1.11M as of Q3 2020.
  • BioNTech was a new TT International position in Q3 2020.
  • BioNTech made up 0.06% of TT International's portfolio in Q3 2020, its #44 holding.
  • 147 funds tracked by Wall St. Rank held BioNTech as of Q3 2020.

Based on TT International's 13F filing for Q3 2020, filed 13 Nov 2020.